Results
response to SEW2871 stimulation in S1P 1 -CHO cells but not S1P 3 -CHO cells ( Figure 1A ). However, S1P, a nonselective agonist, induced phosphorylation of ERK1/2 Both S1P and SEW2871 Induce Activation of MAP Kinase and Akt Pathways and Akt in both S1P 1 -CHO and S1P 3 -CHO cells (data shown for S1P 1 
-CHO cells only). S1P has been reported to activate mitogen-activated protein kinases (MAP kinases) in many systems [34-
The relative potencies of S1P, AFD(R), and SEW2871 ( Figures 1B-1D ) for kinase activation and GTPγS bind-40]. Therefore, we examined the phosphorylation of extracellular signal-regulated kinase 1 (ERK1) and ERK2 ing were determined by EC 50 measurement. S1P was more potent in inducing ERK/Akt phosphorylation than in CHO cells stably transfected with S1P 1 . Phosphorylation of both ERK1 and ERK2 was increased in a con-SEW2871. For instance, S1P at 5 nM was sufficient to induce maximal phosphorylation of Akt, whereas 500 centration-dependent manner after stimulation of cells with S1P for 5 min ( Figure 1A ). SEW2871, a S1P 1 renM of SEW2871 was needed to induce the same level of Akt phosphorylation ( Figure 1A ). This relative difceptor-selective agonist, also induced concentrationdependent phosphorylation of ERK1 and ERK2. Both ference in potency on downstream signal generation was even more obvious when comparing AFD(R) to S1P and SEW2871 induced phosphorylation of Akt ( Figures 1A, 1B, and 1C tions that were three to four orders of magnitude lower than SEW2871 (Table 1) . This suggested that ligand SEW2871 is an S1P 1 -selective full agonist (inducing responses equivalent to 100% of those seen with the binding and downstream signaling were greatest for AFD(R), intermediate for S1P, and least for SEW2871 at physiological ligand S1P) in GTPγS binding, calcium flux, and cell migration assays [24] . S1P 1 selectivity of subnanomolar ligand concentrations. However, all three ligands were full agonists inducing phosphorylation of SEW2871 action on kinase activation is shown in Figure  1A . ERK1/2 and Akt phosphorylation was observed in these signaling molecules to the same extent, provided We next examined the time course of phosphorylation of ERK1, ERK2, and Akt for AFD(R), S1P, and SEW2871. The kinetics of phosphorylation was similar for all three ligands, and data is shown for SEW2871 ( Figures 2D-2F ). As shown in Figures 2D-2E , both ERK1 and ERK2 phosphorylation was maximal at 5 min stimulation, and the level of phospho-ERK decreased with time, but the level of phospho-ERK remained elevated for at least 4.5 hr of stimulation. On the other hand, Akt phosphorylation was near maximal level up to 1 hr of stimulation with SEW2871 but decreased to basal level by 4.5 hr ( Figure 2F ).
To help define the G proteins that are involved in the agonist-induced Akt and ERK phosphorylation, we examined the effect of G i/o inhibitor pertussis toxin (PTx) [44] . Preincubation of the S1P 1 -CHO cells with PTx completely inhibited both ERK and Akt phosphorylation in response to AFD(R) and SEW2871 ( Figure 3A) . The PTx-induced inhibition of the phosphorylation was almost complete when stimulated with S1P ( Figure 3A) . This suggests that all the agonists tested share the ERK and Akt signaling pathways through activation of G i/o protein and that G i/o protein activation is formally upstream of kinase recruitment.
Both S1P and SEW2871 Induce Activation of Rac GTPase Small GTPases of the Rho family, including Rac1, Rho, and Cdc42, play an important role in cytoskeletal changes and cell motility in response to receptor stimulation [45, 46]. S1P has been reported to elicit either stimulatory or inhibitory effects on cell migration, depending on cell type and availability of S1P receptor subtypes [47, 48]. We have examined whether S1P activates Rac1 in CHO cells stably transfected with S1P 1 . 6D) , with signifident on these ion-pairing residues but to a lesser extent ( Figure 6E) . Interestingly, these ion-pairing defective cant phosphorylation of ERK2 and Akt. This suggests that SEW2898 contains the minimum structural requiremutants also showed less phosphorylation of ERK1/2 and Akt than the wild-type receptor upon stimulation ment for S1P 1 agonism. These analogs, however, showed different interactions with mutant receptors, compared with SEW2871 ( Figure 6B) Figures 2A-2C and derstanding of the molecular mechanisms underlying Table 1 ) had an EC 50 approximately 3-to 10-fold less the different potencies of S1P receptor activation in than that induced by S1P and may reflect the imporboth model systems and primary cells and tissues. tance of the aromatic substituent within its acyl chain These studies over time will shed light on mechanisms ( Figure 1D ). SEW2871 was measurably less potent at by which S1P receptors couple to multiple downstream both G protein binding and kinase activation than effector functions and differentially regulate multiple AFD(R) and S1P (Table 1) . SEW2871 was also less pophysiological events. They will also provide a fundatent at Rac activation ( Figure 3B) . Therefore, the unique mental basis that could exploit these molecular sysstructure of SEW2871 provides this agonist with S1P 1 -tems on therapies for immune and cardiovascular disselectivity but with lower potency. This difference in poeases as well as cancer. tency in kinase activation is maintained in in vivo activity for the immunosuppression caused by lymphocyte Significance sequestration.
group-containing ligands S1P or AFD(R). Kinase phoschemical probes of protein function will further the unphorylation induced by AFD(R) (
At least three mechanisms may contribute to differIt is possible to define off-the-shelf compounds from ences in potency of agonism downstream of S1P 1 
